tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Want to see KROS full AI Analyst Report?

Compare Keros Therapeutics (KROS) vs. Competitors

362 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$11.67
$238.84M
-8.08
-13.91%
6 Buy
3 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$6.81
$724.55M
-18.47
-21.20%
2 Buy
0 Hold
0 Sell
Moderate Buy
KalVista Pharmaceuticals
$20.48
$1.37B
-36.71
119.28%
2 Buy
6 Hold
0 Sell
Hold
Palvella Therapeutics
$130.01
$1.74B
-25.86
426.43%
13 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$17.51
$1.71B
-5.04
71.37%
7 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$24.01
$1.48B
-6.21
71.97%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
12.07
-1.58
-11.58%
GYRE
Gyre Therapeutics
7.47
-2.06
-21.62%
KALV
KalVista Pharmaceuticals
26.73
14.83
124.62%
PVLA
Palvella Therapeutics
121.29
98.52
432.67%
NRIX
Nurix Therapeutics
16.52
7.02
73.89%
BCAX
Bicara Therapeutics Inc.
22.58
9.61
74.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts